Clinical Trial Update: A Dose Ranging Study Evaluating Efficacy and Safety of NI-03 [Phase 1, Phase 2]

View source ↗

Summary

A dose-ranging clinical trial updating on the efficacy and safety of NI-03 in chronic pancreatitis, completed phases 1 and 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• NI-03

Snippet

Sponsor: Kangen Pharmaceuticals, Inc | Conditions: Chronic Pancreatitis | Phase 1, Phase 2 | Status: COMPLETED